Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Terbinafine Treatment of Axial Spondyloarthropathy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05119712
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:36.789171+00:00
Published At
2023-08-28T00:00:00+00:00
Record Updated At
2023-08-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Ankylosing Spondylitis", "Axial Spondyloarthritis", "Psoriatic Spondylitis", "Spondylitis Secondary to Inflammatory Bowel Disease", "Axial Spondyloarthopathy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-28"
protocolSection.identificationModule.nctId
"NCT05119712"
protocolSection.identificationModule.officialTitle
"Terbinafine Treatment of Axial Spondyloarthropathy"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Ankylosing Spondylitis (protocolSection.conditionsModule.conditions)
  • Axial Spondyloarthritis (protocolSection.conditionsModule.conditions)
  • Psoriatic Spondylitis (protocolSection.conditionsModule.conditions)
  • Spondylitis Secondary to Inflammatory Bowel Disease (protocolSection.conditionsModule.conditions)
  • Axial Spondyloarthopathy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.